Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease

被引:0
|
作者
Sandra Lemesch
Werner Ribitsch
Gernot Schilcher
Walter Spindelböck
Hildegard Hafner-Gießauf
Gunther Marsche
Lisa Pasterk
Doris Payerl
Bianca Schmerböck
Monika Tawdrous
Alexander R. Rosenkranz
Philipp Stiegler
Gerd Kager
Seth Hallström
Karl Oettl
Katharina Eberhard
Angela Horvath
Bettina Leber
Vanessa Stadlbauer
机构
[1] Medical University of Graz,Department of Internal Medicine, Division of Gastroenterology and Hepatology
[2] Medical University of Graz,Department of Internal Medicine, Clinical Division of Nephrology
[3] Intensive Care Unit,Department of Internal Medicine
[4] Medical University of Graz,Department of Surgery, Division of Transplantation Surgery
[5] Institute of Experimental and Clinical Pharmacology,undefined
[6] Medical University of Graz,undefined
[7] Graz,undefined
[8] Institute of Physiological Chemistry,undefined
[9] Center of Physiological Medicine,undefined
[10] Medical University of Graz,undefined
[11] Medical University of Graz,undefined
[12] Core Facility Computational Bioanalytics,undefined
[13] Center for Medical Research,undefined
[14] Medical University of Graz,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Bacterial infection and sepsis are common complications of chronic kidney disease (CKD). A vicious cycle of increased gut permeability, endotoxemia, inadequate activation of the innate immune system and resulting innate immune dysfunction is hypothesized. We assessed endotoxemia, neutrophil function and its relation to oxidative stress, inflammation and gut permeability in patients with CKD grade 3–5 without renal replacement therapy (CKD group, n = 57), patients with CKD stage 5 undergoing haemodialysis (HD, n = 32) or peritoneal dialysis (PD, n = 28) and patients after kidney transplantation (KT, n = 67) in a cross-sectional observational study. In HD patients, endotoxin serum levels were elevated and neutrophil phagocytic capacity was decreased compared to all other groups. Patients on HD had a significantly higher mortality, due to infections during follow up, compared to PD (p = 0.022). Oxidative stress, neutrophil energy charge, systemic inflammation and gut permeability could not completely explain these differences. Our findings suggest that dialysis modality and not renal function per se determine the development of neutrophil dysfunction and endotoxemia in CKD-patients. HD patients are particularly prone to neutrophil dysfunction and endotoxemia whereas neutrophil function seems to improve after KT. Multi-target approaches are therefore warranted to improve neutrophil function and potentially reduce the rate of infections with patients undergoing haemodialysis.
引用
收藏
相关论文
共 50 条
  • [21] ASSESSMENT OF PHYSICAL ACTIVITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND RENAL REPLACEMENT THERAPY
    Hayhurst, William S. G.
    Ahmed, Aimun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [22] Extrapulmonary tuberculosis in patients with chronic kidney disease receiving renal replacement therapy
    Johnson, Emma
    Shah, Krishna
    Rahman, Ananna
    Mccafferty, Kieran
    Tiberi, Simon
    Kunst, Heinke
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [23] Renal replacement therapy for stage 5 chronic kidney disease in the Cayman Islands
    Shamir O. Cawich
    Nelson Iheonunekwu
    Frits Hendriks
    Greg Hoeksema
    International Urology and Nephrology, 2010, 42 : 461 - 464
  • [24] Psychosocial factors in people with chronic kidney disease prior to renal replacement therapy
    McKercher, Charlotte
    Sanderson, Kristy
    Jose, Matthew D.
    NEPHROLOGY, 2013, 18 (09) : 585 - 591
  • [25] The Management of Chronic Kidney Disease not Requiring Renal Replacement Therapy in General Practice
    Kiel, Simone
    Negnal, Martha
    Stracke, Sylvia
    Fleig, Susanne
    Kuhlmann, Martin K.
    Chenot, Jean-Francois
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2025, 122 (02):
  • [26] ACUTE PANCREATITIS IN ADVANCED CHRONIC KIDNEY DISEASE, RENAL REPLACEMENT THERAPY AND KIDNEY TRANSPLANTED PATIENTS
    Kroner, Paul T.
    Kesler, Alex M.
    Abader, Peter
    Afsh, Mohammad
    Raimondo, Massimo
    GASTROENTEROLOGY, 2019, 156 (06) : S339 - S340
  • [27] HYPOLIPIDEMIC THERAPY AND CHRONIC KIDNEY DISEASE: EFFECTS ON CARDIOVASCULAR RISKS AND RENAL DYSFUNCTION
    Aitbaev, K. A.
    Murkamilov, I. T.
    Fomin, V. V.
    KARDIOLOGIYA, 2019, 59 (02) : 79 - 87
  • [28] What Determines Whether a Patient Initiates Chronic Renal Replacement Therapy?
    Germain, Michael J.
    Cohen, Lewis M.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (08): : 1276 - 1278
  • [29] Surgical Aortic Valve Replacement and Renal Dysfunction: From Acute Kidney Injury to Chronic Disease
    Lacquaniti, Antonio
    Ceresa, Fabrizio
    Campo, Susanna
    Smeriglio, Antonella
    Trombetta, Domenico
    Patane, Francesco
    Monardo, Paolo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)